Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederjnj.com
Get the latest updates from RSS Feed ALL directly as they happen.
Follow now 190 followers
Last updated about 3 hours ago
about 3 hours ago
1 day ago
Submission is supported by 24-week results from the Phase 3b APEX study...
1 day ago
Early VIRTUGUIDE™ surgeons report a 30-minute reduction in surgical time versus traditional...
6 days ago
Early data from robust Autonomy Phase 2b posdinemab trial demonstrate Company’s leadership...
7 days ago
Landmark approval is based on results from the Phase 3 AQUILA study...
7 days ago
Ibrutinib is the first approved Bruton’s tyrosine kinase (BTK) inhibitor to demonstrate...
8 days ago
Agreement enhances the Early Intervention portfolio to tackle the increasing burden of...
9 days ago
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the...
13 days ago
Survey of nearly 700 clinicians across more than 600 surgical facilities in...
13 days ago
New Drug Application supported by results from the Phase 2b SunRISe-1 study